» Articles » PMID: 24797997

Associations of Host Genetic Variants on CD4⁺ Lymphocyte Count and Plasma HIV-1 RNA in Antiretroviral Naïve Children

Overview
Specialty Pediatrics
Date 2014 May 7
PMID 24797997
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: CD4 T-lymphocyte (CD4) counts and HIV plasma RNA concentration (RNA) are 2 key HIV disease markers. The complex interplay between virus and host genetics may contribute to differences in viral set point and CD4 status. Determining the effects of host genetic variation on HIV disease markers is often complicated by the use of antiretroviral therapy. In this study, the association between genetic variants and baseline HIV RNA and CD4 counts was examined in a large cohort of antiretroviral naïve children.

Methods: Specimens from 1053 HIV-infected children were screened for single nucleotide polymorphisms in 78 regions from 17 genes. Linear regression with a robust variance estimator was used to test the association between genetic markers with HIV RNA and CD4 count, controlling for age, race/ethnicity and study. False discovery rate (FDR) controlling was used to adjust for multiple testing.

Results: The study population was 60% black, 26% Hispanic and 13% white; median age 2.35 years; 55% female. Baseline median CD4 count was 780/mm; median log10 HIV RNA was 5.17 copies/mL. For analyses of the associations of genetic makers with baseline CD4 count, 6 HLA and 4 additional markers exhibited P < 0.05, but none met the criteria for statistical significance with FDR controlled at 0.05. For baseline HIV RNA, HLA DRB1*15, DRB1*10, B-27/57, B-14, Cw-8, B-57 were statistically significant with FDR controlled at 0.05.

Conclusions: These results provide strong evidence that HLA DRB1*15, DRB1*10, B-27/57, B-14, Cw-8, B-57 are associated with HIV RNA and play a role in HIV pathogenesis in infected children.

Citing Articles

Early risk warning system for distant metastasis of hepatitis B virus-associated hepatocellular carcinoma with portal vein tumor thrombus.

Li M, Zhao Y, Liu X, Zhang S, Jiang Y, Yang Z Oncol Lett. 2020; 19(4):3249-3257.

PMID: 32256820 PMC: 7074481. DOI: 10.3892/ol.2020.11423.


Associations of Genetically Determined Continental Ancestry With CD4+ Count and Plasma HIV-1 RNA Beyond Self-Reported Race and Ethnicity.

Brummel S, Singh K, Maihofer A, Farhad M, Qin M, Fenton T J Acquir Immune Defic Syndr. 2015; 71(5):544-50.

PMID: 26536313 PMC: 4788562. DOI: 10.1097/QAI.0000000000000883.


Immunity to HIV in Early Life.

Muenchhoff M, Prendergast A, Goulder P Front Immunol. 2014; 5:391.

PMID: 25161656 PMC: 4130105. DOI: 10.3389/fimmu.2014.00391.

References
1.
Lettre G, Lange C, Hirschhorn J . Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol. 2007; 31(4):358-62. DOI: 10.1002/gepi.20217. View

2.
Singh K, Lieser A, Ruan P, Fenton T, Spector S . An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children. J Allergy Clin Immunol. 2008; 122(1):173-80, 180.e1-2. PMC: 2748310. DOI: 10.1016/j.jaci.2008.05.025. View

3.
Singh K, Gray P, Wang Y, Fenton T, Trout R, Spector S . HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children. J Acquir Immune Defic Syndr. 2011; 57(1):32-9. PMC: 3107908. DOI: 10.1097/QAI.0b013e3182119244. View

4.
Englund J, Baker C, Raskino C, McKINNEY R, Petrie B, Fowler M . Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med. 1997; 336(24):1704-12. DOI: 10.1056/NEJM199706123362403. View

5.
Migueles S, Sabbaghian M, Shupert W, Bettinotti M, Marincola F, Martino L . HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A. 2000; 97(6):2709-14. PMC: 15994. DOI: 10.1073/pnas.050567397. View